Elekta’s Nomination Committee for the Annual General Meeting 2013
ET | Source:Elekta AB
In accordance with the decision at the Annual General Meeting on September 4,
2012, Elekta’s Chairman of the Board has contacted the company’s largest
shareholders to form a Nomination Committee. Subsequently, the shareholders
agreeing to participate in the work of the Nomination Committee has each
appointed a member.
The Nomination Committee that will prepare matters prior to the Annual General
Meeting 2013 consists of Anders Oscarsson, AMF Insurance and Funds, Åsa Nisell,
Swedbank Robur funds, Ossian Ekdahl, Första AP-Fonden, Laurent Leksell,
representing his private and companies’ holdings, and Akbar Seddigh, Chairman of
the Board. The Nomination Committee will appoint one of the members as Chairman.
Combined, the shareholders in the Nomination Committee represented approximately
38 percent of the votes in Elekta AB on September 28, 2012.
Shareholders wishing to submit proposals to Elekta’s Nomination Committee can do
so by e-mail at firstname.lastname@example.org or by letter to: Elekta AB, Nomination
Committee, Box 7593, SE-103 93 Stockholm, Sweden.
The Committee’s assignment remains effective until a new Nomination Committee is
For further information, please contact:
Johan Andersson Melbi, Investor Relations Manager, Elekta AB.
Tel: +46 702 100 451, email: email@example.com.
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 08.00 CET on October 24, 2012.
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both healthcare providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
2321 Rosecrans Avenue.
El Segundo, CA 90245 Phone: (800) 307-6627 Fax: (800) 307-3567
25 Basinghall Street,
London EC2V 5HA
UK Phone: +1 866-465-8454